Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Blood Test Identifies Risk of Sudden Cardiac Death

Published: Wednesday, June 25, 2014
Last Updated: Wednesday, June 25, 2014
Bookmark and Share
The test, PED MASTR, is already in use at the center of medical genetics of UZA/UAntwerp and will be launched worldwide from September 2014.

UAntwerp (University of Antwerp), UZA (Antwerp University Hospital), and Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests, together developed a blood test to determine the genetic risk of “Sudden Cardiac Death” (SCD). 

SCD, which affects one in a thousand people, can be reduced with the PED MASTR. Especially young, seemingly healthy individuals are affected by SCD, as indicated by the regular reports of the unexpected death of young athletes during a sports competition or – training. 

The heart rhythm abnormalities linked with these deaths are unfortunately difficult to detect, even for cardiologists. Genetic predisposition plays an important role as family members of affected individuals have a 50% risk of inheriting the same genetic predisposition to develop cardiac disease. 

Early detection of hereditary heart disease in high--‐risk families can save lives. With the development of the PED MASTR it has become feasible and fast to fully analyze the high number of genes involved for SCD causing mutations. 

“This new kit, using our MASTR technology, comprising 51 genes, allows physicians to identify all genetic mutations at once and use this information to propose appropriate treatment. This has been a unique project, bringing together the expertise of clinicians, geneticists and diagnostic developers to deliver to society a product that will save young lives“, said dr. Dirk Pollet, CEO of Multiplicom. 

According to prof. Bart Loeys, prof. Christiaan Vrints, and dr. Johan Saenen, all UZA/UAntwerp, this new test accelerates the diagnostic process in patients or family members experiencing SCD. “This test nicely complements our existing clinical cardiac--‐ and genetic expertise and offers the option to pre--‐symptomatic but mutation--‐carrying individuals to implement preventive measures to avoid SCD.” 

This new product has been developed with the support of the IWT (Agency for Innovation by Science and Technology). 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!